These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 30356548)

  • 1. Exercise is…?: A commentary response.
    Robertson-Wilson J; Fortier M
    J Sport Health Sci; 2017 Mar; 6(1):52-53. PubMed ID: 30356548
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcranial magnetic stimulation in sport science: a commentary.
    Goodall S; Howatson G; Romer L; Ross E
    Eur J Sport Sci; 2014; 14 Suppl 1():S332-40. PubMed ID: 24444227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of brain-derived neurotrophic factor (BDNF) and exercise intensity on memory in the adolescent brain: a commentary.
    Tharmaratnam T; Tabobondung T; Tabobondung T; Doherty S
    Environ Health Prev Med; 2018 Apr; 23(1):12. PubMed ID: 29614951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Habitual exercise and vascular function.
    Barnes JN; Tanaka H
    J Appl Physiol (1985); 2008 Aug; 105(2):777. PubMed ID: 18678640
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Enhanced vascular function: a rationale for exercise and marker of cardiovascular health.
    Elliott M
    J Appl Physiol (1985); 2008 Aug; 105(2):776. PubMed ID: 18678639
    [No Abstract]   [Full Text] [Related]  

  • 6. The exercise standards from the American Heart Association--a commentary.
    Fletcher GF
    J Med Assoc Ga; 1991 Feb; 80(2):89-92. PubMed ID: 2007834
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Ameredes BT
    J Appl Physiol (1985); 2008 Aug; 105(2):769. PubMed ID: 18678632
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Wagner PD
    J Appl Physiol (1985); 2008 Aug; 105(2):774. PubMed ID: 18678637
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Higashi Y
    J Appl Physiol (1985); 2008 Aug; 105(2):770. PubMed ID: 18678633
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Leicht AS; Tulppo MP; Golledge J
    J Appl Physiol (1985); 2008 Aug; 105(2):775. PubMed ID: 18678638
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Considering the role of sex in modulating direct effects of exercise on the vasculature.
    Parker B; Proctor D
    J Appl Physiol (1985); 2008 Aug; 105(2):778. PubMed ID: 18678641
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Iwamoto GA; Nelson AJ
    J Appl Physiol (1985); 2008 Aug; 105(2):773. PubMed ID: 18678636
    [No Abstract]   [Full Text] [Related]  

  • 13. Exercise has a positive effect on low-grade inflammation in women with breast cancer [commentary].
    Dennett A
    J Physiother; 2016 Oct; 62(4):227. PubMed ID: 27634162
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Lightfoot JT
    J Appl Physiol (1985); 2008 Apr; 104(4):1249. PubMed ID: 18385304
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Thomis M
    J Appl Physiol (1985); 2008 Apr; 104(4):1251. PubMed ID: 18385306
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Gielen S; Hambrecht R; Schuler GC
    J Appl Physiol (1985); 2008 Aug; 105(2):771. PubMed ID: 18678634
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Reid JJ; Hawley JA
    J Appl Physiol (1985); 2008 Aug; 105(2):772. PubMed ID: 18678635
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on "Adapted Motivational Interviewing to Promote Exercise in Adolescents With Congenital Heart Disease: A Pilot Trial".
    Roell E; McQuiddy V
    Pediatr Phys Ther; 2018 Oct; 30(4):334. PubMed ID: 30277968
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing the clinical exercise test: a commentary on the exercise protocol.
    Myers J
    Heart Fail Monit; 2004; 4(3):82-9. PubMed ID: 15772703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Pescatello LS
    J Appl Physiol (1985); 2008 Apr; 104(4):1247. PubMed ID: 18385302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.